Discovery and chemical affinity
In 1935, the German researcher G. Domagk discovered a pronounced antimicrobial effect in a drug called prontosil (also known as red streptocide). It was subsequently found that prontosil itself is only a precursor. Upon entering the human body, it undergoes metabolic transformations, as a result of which the truly active substance — sulfanilamide (white streptocide) — is released. This discovery marked the beginning of the creation of an entire class of drugs.
The main secret to the efficacy of these drugs lies in their molecular structure. Sulfonamides are structural analogs of para-aminobenzoic acid (PABA). PABA itself is a vital component for microorganisms, as it is part of the folic acid molecule. Folic acid is constructed from three basic building blocks: pterin, PABA, and glutamic acid. Sulfonamides share a common formula containing a sulfonamide group, where various radicals determine the properties of a specific drug (e.g., a hydrogen atom in streptocide, an acetyl group in albucid, and a heterocycle with methyl groups in sulfadimezine).
Molecular mechanisms of the bacteriostatic effect
Based on their pharmacological action, sulfonamides are bacteriostatic agents. They do not kill bacteria instantly, but reliably halt their further growth and reproduction.
This effect is based on the phenomenon of competitive inhibition. Because a sulfonamide molecule closely resembles PABA in structure, it can displace PABA in the bacterial enzyme — dihydropteroate synthase. Normally, this enzyme captures PABA to assemble folic acid. The presence of the drug leads to the sulfonamide taking the place of PABA in the active site of the enzyme.
The result of this substitution is the complete blockade of folic acid synthesis inside the bacterial cell. Because folates are critically required by microorganisms for the biosynthesis of nucleic acids (DNA and RNA), a folic acid deficiency makes the duplication of genetic material impossible. As a result, the bacterial cell loses its ability to divide.
Enzyme kinetics and the loading dose rule
The biochemical essence of competitive inhibition is clearly manifested when analyzing the kinetic constants of the enzymatic reaction:
- Maximum reaction velocity ($V_{max}$) does not change. This means that if a massive excess of PABA were theoretically present in the medium, it would be able to displace the inhibitor, and the enzyme would operate at full capacity.
- Michaelis constant ($K_m$) increases significantly. This indicates that the affinity of dihydropteroate synthase for its true substrate (PABA) sharply decreases in the presence of the inhibitor.
It is this biochemical feature that dictates strict rules for the clinical use of these drugs. For treatment to be effective, it is necessary to create a drug concentration in the blood that significantly exceeds the concentration of PABA in tissues. To achieve this, therapy is always initiated with a so-called loading dose. This allows for a sharp shift in the equilibrium of the competition for the enzyme's active center in favor of the drug.
Biochemical basis of selective toxicity
One of the main questions when studying antibacterial agents is why they are lethal to microbes while safe for humans. In the case of sulfonamides, the answer lies in folate metabolism.
To survive, bacteria must synthesize folic acid de novo (from scratch). Human cells, on the other hand, are incapable of synthesizing folic acid on their own and obtain it exclusively in ready-made form from food (as a vitamin). Consequently, human cells simply lack the enzyme dihydropteroate synthase—the target for sulfonamides—which ensures their selective toxicity.
Briefly: answers to topical questions
With which drug (a dihydrofolate reductase inhibitor) are sulfonamides combined to achieve a bactericidal effect?
Sulfonamides are combined with trimethoprim.
Examples of confirmed combinations:
- Co-trimoxazole — sulfamethoxazole + trimethoprim.
- Lidaprim — sulfametrole + trimethoprim.
- Sulfatone — sulfamonomethoxine + trimethoprim.
- Poteseptyl — sulfadimidine + trimethoprim.
What adverse urinary system reactions are characteristic of sulfonamides?
Sulfonamide drugs are characterized by specific kidney damage, which manifests as crystalluria.
- Mechanism of development — the drugs are metabolized in the liver via acetylation. The resulting acetylated metabolites have significantly worse solubility compared to the parent active substance.
- Conditions of occurrence — under an acidic urine reaction (low pH), poor solubility leads to the substances precipitating out to form crystals. The risk of complication is higher when taking short-acting drugs.
- Prevention — patients require abundant alkaline fluids (mineral water, baking soda solution) to alkalinize the urine.
Sulfonamides play a game of "musical chairs" with PABA for a spot on the dihydropteroate synthase enzyme. To guarantee a win, there must be a very high number of drug molecules—hence the need for a loading dose.
Class and exam questions
Why do sulfonamides not disrupt human folate metabolism?
Human cells cannot synthesize folic acid on their own, but receive it in ready-made form from food. Therefore, the target enzyme for sulfonamides simply does not exist in the human body.
Why is a "loading" initial dose prescribed during sulfonamide treatment?
Inhibition is competitive and reversible. For drug molecules to reliably displace PABA from the active center of the enzyme, their initial concentration must be very high.
How do the kinetic constants of an enzyme change under the action of sulfonamides?
The maximum reaction velocity ($V_{max}$) does not change, as inhibition is surmountable with an excess of substrate. However, the Michaelis constant ($K_m$) increases, reflecting a decrease in the enzyme's affinity for PABA.
What else to study on this topic
- Chemical structure of various sulfonamide radicals (Streptocide, Albucid, Sulfadimezine)
- Structure and components of folic acid (pterin, PABA, glutamic acid)
- Metabolism of Prontosil in the human body
- The connection between folic acid deficiency and bacterial nucleic acid synthesis
Master the entire topic in the "Biochemistry" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on the "Mechanism of Action of Sulfonamides" and 3,616 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 115 video lessons on the subject
Other topics in the "Enzymology" section
Free video lessons: biochemistryShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.